Korea should depend on biopharmaceuticals

Published: 2007-05-07 06:59:00

Updated: 2007-05-07 06:59:00

Domestic drug makers should focus on research and development of new biodrugs to survive in an era of the Korea-U.S. FTA via closer collaboration among related circles to innovate internal structures, said Chung Koo-hun Samsung Economic Institute on May 3.

They should pursue the knowledge-inte...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK